Carlos J. Soriano Navarro *

Autor invitado por SIIC

La resonancia magnética puede distinguir la disfunción sistólica del ventrículo izquierdo relacionada o no con enfermedad coronaria subyacente

DIAGNÓSTICO DE ENFERMEDAD CORONARIA EN PACIENTES CON INSUFICIENCIA CARDÍACA POR RESONANCIA MAGNÉTICA CON REALCE TARDÍO DE GADOLINIO

En los pacientes con insuficiencia cardiaca y disfunción sistólica del ventrículo izquierdo de etiología incierta la resonancia magnética cardiovascular con realce tardío de gadolinio es una excelente herramienta para la clasificación de los pacientes en base a la presencia o ausencia de enfermedad coronaria obstructiva subyacente y puede ofrecer una alternativa válida a la coronariografía para la detección de enfermedad coronaria.

*Carlos J. Soriano Navarro
describe para SIIC los aspectos relevantes de su trabajo
NONINVASIVE DIAGNOSIS OF CORONARY ARTERY DISEASE IN PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF UNCERTAIN ETIOLOGY, USING LATE GADOLINIUM-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE
Institución principal de la investigación
*Consorcio Hospital General Universitario de Valencia, Valencia, España
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
1. Gheorghiade M, Bonow RO, Chronic heart failure in the United States: a manifestation of coronary artery disease, Circulation 97 (1998), pp. 282-289.
2. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). 2001. American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htm. Accessed October 2003.
3. Sutton GC, Epidemiologic aspects of heart failure, Am Heart J 120 (1990), 1538-1540.
4. Remme WJ, Swedberg K, Cleland J et al. Guidelines for the diagnosis and treatment of chronic heart failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology, Eur Heart J 22 (2001), 1527-1560.
5. Bart BA, Shaw LK, McCants CB et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or non-ischemic cardiomyopathy, J Am Coll Cardiol 30 (1997), 1002-1008.
6. Adams KF, Dunlap SH, Sueta CA et al. Relation between gender, etiology and survival in patients with symptomatic heart failure, J Am Coll Cardiol 28 (1996), 1781-1788.
7. Felker GM, Shaw LK, O'Connor CM. A standarized definition of ischemic cardiomyopathy for use in clinical research, J Am Coll Cardiol 39 (2002), 210-218.
8. Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Surgery Trialists Collaboration, Lancet 344 (1994), 563-570.
9. Eagle K, Guyton RA, Davidoff R et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Disease Bypass Graft Surgery), J Am Coll Cardiol 34 (1999), 1262-1347.
10. Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, Am J Cardiol 90 (2002), 29-34.
11. Schalla S, Nagel E, Lechmkuhl H et al. Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography, Am J Cardiol 87 (2001), 95-99.
12. Bellenger NG, Burgess MI, Ray G et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance, Eur Heart J 21; (2000), 1387-1396.
13. Anderson LJ, Holden S, Davies B et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J 22 (2001), 2171-2179.
14. Moon JCC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non diagnostic echocardiography, Heart 90 (2004), 645-649.
15. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy, Am Heart J 136 (1998), 824-830.
16. Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: comparison to histology and molecular pathology, Circulation 109 (2004), 1250-1258.
17. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med 343 (2000), 1445-1453.
18. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of the presence, location and transmural extent of healed Q-wave and non–Q-wave myocardial infarction, Lancet 357 (2001), 21-28.
19. McCrohon JA, Moon JCC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation 108 (2003), 54-59.
20. Bello D, Shah DJ, Farah GM et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy, Circulation 108 (2003), 1945-1953.
21. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol 36 (2000), 959-969.
22. Lauer MS, Larson MG, Levy D. Gender-specific reference M-mode values in adults: population-derived values with consideration of the impact of height, J Am Coll Cardiol 26 (1995), 1039-1046.
23. Simonetti OP, Kim RJ, Fieno DS et al. An improved magnetic resonance imaging technique for the visualization of myocardial infarction, Radiology 218 (2001), 215-223.
24. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP. Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging, J Cardiovasc Magn Reson 1 (1999), 7-21.
25. Penell DJ. Ventricular volume and mass by cardiovascular magnetic resonance, J Cardiovasc Magn Reson 4 (2002), 507-513.
26. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Circulation 105 (2002), 539-542.
27. Rahimtoola SH. Concept and evaluation of hibernating myocardium, Annu Rev Med 50 (1999), 75-86.
28. Elsasser A, Schelepper M, Klovekorn WP et al. Hibernating myocardium: an incomplete adaptation to ischemia, Circulation 96 (1997), 2920-2931.
29. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease, Circulation 101 (2000), 570-580.
30. Falk E, Shah PK, Fuster V. Coronary plaque disruption, Circulation 92 (1995), 657-671.
31. Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy, Tex Heart Inst J 29 (2002), 176-180.
32. Choudhury L, Mahrholdt H, Wafner A et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy, J Am Coll Cardiol 40 (2002), 2156-2164.
33. Moon JCC, Reed E, Sheppard MN et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy, J Am Coll Cardiol 43 (2004), 2260-2264.
34. Moon JCC, McKenna WJ, McCrohon JA, Elliot PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance, J Am Coll Cardiol 41 (2003), 1561-1567.
35. Moon JCC, Sachdev B, Elkington AG et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease (1) Evidence for a disease specific abnormality of the myocardial interstitium, Eur Heart J 24 (2003), 2151-2155.
36. Moon JCC, Mundy HR, Lee PJ, Mohiaddin RH, Pennell DJ. Myocardial fibrosis in glycogen storage disease type 3, Circulation 107 (2003), e47.